Recommendations on the statistical analysis of the Comet assay

Jonathan Bright1, Mike Aylott, Simon Bate

  • 1Discovery Statistics, AstraZeneca R&D, Macclesfield, Cheshire, UK. jonathan.bright@astrazeneca.com

Pharmaceutical Statistics
|December 1, 2011
PubMed
Summary

Statisticians in the Pharmaceutical Industry (PSI) Toxicology Special Interest Group discussed the Comet assay, a key safety study component. They provided recommendations for analyzing its complex data, often lognormal, to improve regulatory submissions.

Related Concept Videos